Simeprevir Sodium Patent Expiration
Simeprevir Sodium is Used for treating hepatitis C. It was first introduced by Janssen Products Lp
Simeprevir Sodium Patents
Given below is the list of patents protecting Simeprevir Sodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Olysio | US7671032 | HCV NS-3 serine protease inhibitors | May 19, 2025 | Janssen Prods |
| Olysio | US8148399 | Macrocyclic inhibitors of hepatitis C virus | Sep 05, 2029 | Janssen Prods |
| Olysio | US8349869 | Macrocylic inhibitors of hepatitis C virus | Jul 28, 2026 | Janssen Prods |
| Olysio | US8741926 | Macrocyclic inhibitors of hepatitis C virus | Jul 28, 2026 | Janssen Prods |
| Olysio | US8754106 | Macrocyclic inhibitors of hepatitis C virus | Jul 28, 2026 | Janssen Prods |
| Olysio | US9040562 | Macrocyclic inhibitors of hepatitis C virus | Jul 28, 2026 | Janssen Prods |
| Olysio | US9353103 | Macrocyclic inhibitors of hepatitis C virus | Jul 28, 2026 | Janssen Prods |
| Olysio | US9623022 | Macrocyclic inhibitors of hepatitis C virus | Jul 28, 2026 | Janssen Prods |
| Olysio | US9856265 | Macrocyclic inhibitors of hepatitis C virus | Jul 28, 2026 | Janssen Prods |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳